Hot topics for both consumers and webmarketers on WebmasterRadio.FM
Every Wednesday, 5PM Eastern.
Bextra and the FDA
In February of 2005 an FDA advisory panel recommended the FDA allow Bextra and Celebrex to remain on the market, though most experts agreed the drugs presented potentially fatal heart attack and stroke risks. However, the FDA elected to pull Bextra from the market. This was a break from usual practice, as the FDA usually goes along with advisory panel recommendations.
Save Tip
Tip Rating
Comments
Nobody has commented on this tip yet. Be the first.
